心臟瓣膜市场规模、份额及成长分析（按类型、部位、治疗方法、最终用户和地区）－2025-2032 年产业预测

2023 年全球心臟瓣膜市场规模为 86 亿美元，预计将从 2024 年的 95.8 亿美元成长到 2032 年的 227.2 亿美元，预测期内（2025-2032 年）的复合年增长率为 11.4%。

截至 2023 年 10 月，技术进步正在彻底改变心臟衰竭和心血管疾病的管理，为创新治疗方案铺路。心臟疾病盛行率的上升使得人们将注意力集中到有望重塑临床实践的尖端产品的开发上。行业领导者正在推出创新产品来推动市场成长并改善治疗方法。预计2023年至2030年间心臟瓣膜市场将大幅扩张，主要原因是全球心血管疾病患者人数迅速增加。各种心臟疾病（包括瓣膜疾病和冠状动脉疾病）的盛行率不断上升，推动了对更换心臟瓣膜的需求。这些植入在恢復心臟功能和改善患者预后方面发挥重要作用。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术进步

心臟瓣膜市场规模（按类型和复合年增长率）（2025-2032）

• 市场概览
• 经导管心臟瓣膜
• 组织心臟瓣膜
• 人工心臟瓣膜
• 其他的

心臟瓣膜市场规模（依零件划分）及复合年增长率（2025-2032）

• 市场概览
• 二尖瓣
• 主动脉瓣
• 其他地区

心臟瓣膜市场规模（依治疗方法和复合年增长率） (2025-2032)

• 市场概览
• 心臟瓣膜修復
• 心臟瓣膜置换术

心臟瓣膜市场规模（依最终用户和复合年增长率） (2025-2032)

• 市场概览
• 心臟检查
• 医院和诊所
• 专业中心
• 其他的

心臟瓣膜市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Medtronic（Ireland）
• Edwards Lifesciences（United States）
• Boston Scientific（United States）
• Abbott Laboratories（United States）
• LivaNova（United Kingdom）
• CryoLife（United States）
• MicroPort Scientific（China）
• Braile Biomedica（Brazil）
• TTK Healthcare（India）
• Colibri Heart Valve（United States）
• Venus Medtech（China）
• Peijia Medical（China）
• Lepu Medical Technology（China）
• Meril Life Sciences（India）
• Biotronik（Germany）
• Neovasc（Canada）
• Cardiac Dimensions（United States）
• HighLife Medical（France）
• Mardil Medical（United States）

结论和建议

Global Cardiac Valve Market size was valued at USD 8.6 billion in 2023 and is poised to grow from USD 9.58 billion in 2024 to USD 22.72 billion by 2032, growing at a CAGR of 11.4% during the forecast period (2025-2032).

As of October 2023, technological advancements are revolutionizing heart failure and cardiovascular disease management, paving the way for innovative treatment solutions. With the rising prevalence of cardiac conditions, there's an intensified focus on developing cutting-edge products that promise to reshape clinical practices. Major industry players are introducing novel offerings, driving market growth and enhancing treatment methodologies. The cardiac valve market, expected to expand significantly between 2023 and 2030, is primarily propelled by the rapid increase in the global population suffering from cardiovascular diseases. The growing incidence of various heart ailments, including valvular disorders and coronary artery disease, has spurred demand for cardiac valve replacements. These implants play a crucial role in restoring cardiac function, leading to improved patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Valve market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Valve Market Segments Analysis

Global Cardiac Valve Market is segmented by Type, Position, Treatment, End User and region. Based on Type, the market is segmented into Trans-Catheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve and Others. Based on Position, the market is segmented into Mitral Valve, Aortic Valve and Other Position. Based on Treatment, the market is segmented into Cardiac Valve Repair and Cardiac Valve Replacement. Based on End User, the market is segmented into Cardiac Research Institute, Hospital and Clinics, Speciality centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Valve Market

The growth of the Global Cardiac Valve market is primarily driven by an increasing elderly population and a trend toward more sedentary lifestyles. Furthermore, advancements in heart valve technology and a growing awareness of surgical options are contributing to this expansion, particularly as patients prefer minimally invasive procedures. According to the American College of Cardiology, around 5 million Americans are diagnosed with heart valve disease each year, highlighting the urgent need for effective treatments and interventions. This combination of demographic changes, technological innovations, and patient preferences underscores the significant potential for growth within the cardiac valve market.

Restraints in the Global Cardiac Valve Market

The Global Cardiac Valve market faces significant challenges primarily due to stringent government regulations overseeing the development, production, and application of medical devices, particularly cardiac valves. Adherence to these regulatory guidelines requires a complex and labor-intensive process, which involves extensive testing and comprehensive documentation to ensure the safety and efficacy of these devices. This meticulous compliance not only prolongs the time required for product development but also adds considerable costs, ultimately hindering market growth and innovation within the cardiac valve sector. As a result, navigating these regulatory hurdles can deter new entrants and limit advancements in this specialized market.

Market Trends of the Global Cardiac Valve Market

The global cardiac valve market is witnessing robust growth, primarily driven by the rising prevalence of heart valve diseases and the introduction of innovative and regulated cardiac valve solutions. The increasing incidence of conditions such as rheumatic heart disease, affecting approximately 39 million people worldwide according to the World Heart Federation's 2022 data, highlights a significant market need. Additionally, advancements in technology and materials in valve design are enhancing patient outcomes, thereby accelerating adoption rates. This trend reflects a broader healthcare focus on improving cardiovascular health, positioning cardiac valves as a critical area of investment and development within the medical device industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Cardiac Valve Market Size by Type & CAGR (2025-2032)

• Market Overview
• Trans-Catheter Heart Valve
• Tissue Heart Valve
• Mechanical Heart Valve
• Others

Global Cardiac Valve Market Size by Position & CAGR (2025-2032)

• Market Overview
• Mitral Valve
• Aortic Valve
• Other Position

Global Cardiac Valve Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Cardiac Valve Repair
• Cardiac Valve Replacement

Global Cardiac Valve Market Size by End User & CAGR (2025-2032)

• Market Overview
• Cardiac Research Institute
• Hospital and Clinics
• Speciality centers
• Others

Global Cardiac Valve Market Size & CAGR (2025-2032)

• North America (Type, Position, Treatment, End User)
  • US
  • Canada
• Europe (Type, Position, Treatment, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Position, Treatment, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Position, Treatment, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Position, Treatment, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TTK Healthcare (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colibri Heart Valve (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Venus Medtech (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Peijia Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neovasc (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiac Dimensions (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HighLife Medical (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mardil Medical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations